{{Rsnum
|rsid=12199015
|Gene=ENPP3
|Chromosome=6
|position=131737807
|Orientation=plus
|GMAF=0.1373
|Gene_s=ENPP3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 90.3 | 8.8 | 0.9
| HCB | 41.6 | 48.9 | 9.5
| JPT | 40.7 | 49.6 | 9.7
| YRI | 98.0 | 2.0 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 41.6 | 48.9 | 9.5
| CHD | 46.8 | 41.3 | 11.9
| GIH | 65.3 | 28.7 | 5.9
| LWK | 89.1 | 10.9 | 0.0
| MEX | 51.7 | 41.4 | 6.9
| MKK | 90.4 | 9.6 | 0.0
| TSI | 94.1 | 5.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23149075
  |Trait=Response to fenofibrate (adiponectin levels)
  |Title=Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.
  |RiskAllele=
  |Pval=5E-6
  |OR=.09
  |ORtxt=[0.051-0.129] ng/dL increase
  }}

{{on chip | Affy GenomeWide 6}}